Skip to main content

Oncology Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • News
  • Events coverage
  • Features
    • Opinion
    • Journal articles
    • Events calendar
    • Spotlights
    • In Focus

    Follow us on social media

  • Our Journals
  • Topic
    • Prevention, detection and screening
      • Biomarkers
      • Diagnostics
      • Epidemiology
      • Genetics & genomics
      • Prevention & screening
    • Bench to bedside
      • Cancer biology
      • Clinical trials
      • Drug approvals
      • Drug development
      • Emerging technologies
      • Industry & business
      • Preclinical research
    • Treatments
      • Chemotherapy
      • Immuno-oncology
      • Personalized & precision medicine
      • Radiology
      • Surgery
      • Targeted therapies
    • Supportive oncology
      • Palliative care
      • Patient perspectives
      • Quality of life
      • Survivorship
      • Virtual healthcare

    Follow us on social media

  • Disease specialty
    • Breast
    • Colorectal
    • Endocrine
    • Gastrointestinal
    • Genitourinary
    • Gynecologic
    • Head & neck
    • Hematologic
    • Hepatic
    • Lung
    • Neurologic
    • Pancreatic
    • Prostate
    • Rare tumors
    • Renal
    • Skin

    Follow us on social media

  • Multimedia
    • Videos
    • Podcasts
    • Infographics
    • Webinars
    • Downloadable eBooks

    Follow us on social media

  • Register
[COFFEE CHAT] The emotional and psychological impact of hepatocellular carcinoma on patients, families and caregivers WATCH NOW

Cancer biology and pathology

The overarching themes in cancer biology and pathology are proliferation, apoptosis and growth, immunology, invasion/ metastasis and angiogenesis.

View more

The vast majority of human cancers begin are clonal in their origin, meaning that they began from genetic mutations within a single population of precursor or cancer stem cells. However, with subsequent cell divisions, the tumor develops heterogeneity and therefore further abnormalities. The genes most commonly affected and subsequently cancer inducing, control the cell cycle checkpoint, DNA repair, DNA damage repair recognition, apoptosis, differentiation and cell signaling.

Taking apoptosis as an example, normal cells generally die by an active and strictly regulated process known as programmed cell death, disturbances in the balances of proteins that control this cycle can cause cancer. Additionally, tumor cells are often not recognized and destroyed by the immune system either because the tumor does not express molecules that induce cytotoxic T-lymphocytes or because the tumor actively secretes immunosuppression cytokines. Cancers can spread by both local invasion and distant metastases by infiltrating the blood vessels and lymphatic systems.

The articles in this section provide insight into the field of the biology and pathology of cancer through breaking news, peer-reviewed journal articles, expert-opinion pieces and more. If you want access to all of this and more content, and regular updates to your emails, register with Oncology Central now.

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Expert Panel
  • Journals
  • Permissions and content ownership policy
  • Press release policy
  • Whitelist emails

Contact

Contact Us

Office info

Oncology Central is powered by Taylor & Francis Group

Oncology Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Oncology Central